TY - CHAP M1 - Book, Section TI - Transplant Pharmacogenomics A1 - Cadiz, Christine L. A1 - Ha, David R. A2 - Lam, Jerika T. A2 - Gutierrez, Mary A. A2 - Shah, Samit Y1 - 2021 N1 - T2 - Pharmacogenomics: A Primer for Clinicians AB - LEARNING OBJECTIVESDiscuss the clinical considerations of pharmacogenomics in solid organ and hematopoietic stem cell transplantation.Describe general mechanisms of action, pharmacokinetics/pharmacodynamics, adverse drug reactions, and drug interactions of transplant immunosuppressant agents.Identify gene targets that influence pharmacokinetic or pharmacodynamic phenotypes of transplant immunosuppressant agents.Given a case with pharmacogenetic testing results, provide recommendations regarding selection, dosing, monitoring, and other considerations for transplant immunosuppressant agents. SN - PB - McGraw Hill CY - New York, NY Y2 - 2024/03/28 UR - accesspharmacy.mhmedical.com/content.aspx?aid=1179510448 ER -